OQS
AXDX

Occudo Quantitative Strategies’s Accelerate Diagnostics AXDX Stock Holding History

Occudo Quantitative Strategies’s Portfolio AXDX Stock Details AXDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-11,225
Closed -$130K – 678
2024
Q3 		$130K Buy
+11,225
New +$16.6K 0.02% 617

Other funds holding AXDX

AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
GAM
Griffin Asset Management New York $949M AUM 24.98% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BC
Birchview Capital Burlington, Vermont $214M AUM 185.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
CS
Cannell & Spears New York $5.62B AUM 41.25% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
BAM
Belpointe Asset Management Reno, Nevada $3.06B AUM 23.82% 1-Year Est. Return
TWA
TCI Wealth Advisors Tucson, Arizona $2.31B AUM 26.52% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Occudo Quantitative Strategies's AXDX Position: Q4 2024 in Review

Occudo Quantitative Strategies sold out of Accelerate Diagnostics (AXDX) in Q4 2024, closing a stake of 11,225 shares — an estimated $130K sold.

Occudo Quantitative Strategies first reported a position in AXDX in Q3 2024 and held it in 1 quarter. The position peaked at $130K in Q3 2024. 47 funds tracked by Wall St. Rank hold AXDX as of Q4 2024.

  • Occudo Quantitative Strategies reported no remaining Accelerate Diagnostics position as of Q4 2024 after selling out during the quarter.
  • Occudo Quantitative Strategies sold 11,225 Accelerate Diagnostics shares in Q4 2024, an estimated $130K.
  • Occudo Quantitative Strategies first reported a position in Accelerate Diagnostics in Q3 2024 and held it in 1 quarter.
  • Occudo Quantitative Strategies's Accelerate Diagnostics position peaked at $130K in Q3 2024.
  • 47 funds tracked by Wall St. Rank held Accelerate Diagnostics as of Q4 2024.

Based on Occudo Quantitative Strategies's 13F filing for Q4 2024, filed 14 Feb 2025.